Track the ARIAD PHARMACEUTICALS INC stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €84.9m. The latest transaction was filed on 9 February 2016 (Attribution). Among the most active insiders: BERGER HARVEY J M D. The full history is free.
33
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
n/a
8 ops.
Sell Volume
Fundamental score
Ranked 16,944 of 28,932 companies
46.9
score / 100
Value
43
Quality
51
FCF yld-8.6%
Earn yld5.1%
EV/EBITDA12.5x
ROE3.6%
Gross mgn·
Net mgn4.1%
Debt/EBITDA1.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
ARIAD PHARMACEUTICALS INC is a biopharmaceutical company focused on developing treatments for cancer. It specializes in targeted therapies to improve patient outcomes.